Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Precision BioSciences AASLD update call. [Operator ...

Learn more about whether ADMA Biologics, Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A week ago, Arcus Biosciences, Inc. (NYSE:RCUS) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. Revenues of US$26m beat estimates by a ...

Fintel reports that on October 29, 2025, Citigroup maintained coverage of Arcus Biosciences (NYSE:RCUS) with a Buy ...

Arcus Biosciences ( (RCUS)) has released its Q3 earnings. Here is a breakdown of the information Arcus Biosciences presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock ...

Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of $1.27 per share versus the Zacks Consensus Estimate of a loss of $1.33. This compares to a loss of $1 per share a year ago. These ...

Precision BioSciences, Inc. (Nasdaq: DTIL) ("Precision"), a clinical stage gene editing company utilizing its novel ...

Arcus Biosciences’s stock price closed at $19.88. It is up 117.03% in the last 3 months and up 21.15% in the last 12 months. Arcus Biosciences saw 0 positive EPS revisions and 3 negative EPS revisions ...

Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...

Detailed price information for Arcus Biosciences Inc (RCUS-N) from The Globe and Mail including charting and trades.

Investing.com -- Arcus Biosciences, Inc. (NYSE:RCUS) stock fell 8.75% on Friday after the company announced the pricing of a $250 million public offering of common stock.

Arcus Biosciences Inc. (NYSE:RCUS) is one of billionaire Steve Cohen’s 10 small-cap stock picks with huge upside potential. On October 6, Arcus Biosciences Inc. (NYSE:RCUS) announced encouraging data ...